| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 4.80e-06 | 5 | 158 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 7.66e-05 | 11 | 158 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 1.66e-04 | 14 | 158 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | bicarbonate channel activity | 1.86e-04 | 3 | 158 | 2 | GO:0160133 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.09e-04 | 115 | 158 | 6 | GO:0004497 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 3.69e-04 | 4 | 158 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 3.69e-04 | 4 | 158 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 3.69e-04 | 4 | 158 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 3.69e-04 | 4 | 158 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | DMGDH CYP1A1 RSAD1 AOC1 CYP2D7 CYP2D6 KDM5A BCKDHA HPDL CYP2W1 MOXD1 ALDH16A1 FDXR DEGS2 ALDH1A3 HSD17B4 | 3.88e-04 | 766 | 158 | 16 | GO:0016491 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 6.06e-04 | 49 | 158 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | TORC2 complex binding | 6.13e-04 | 5 | 158 | 2 | GO:1904841 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 6.13e-04 | 5 | 158 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 6.13e-04 | 5 | 158 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 7.66e-04 | 23 | 158 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 9.10e-04 | 194 | 158 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 9.14e-04 | 6 | 158 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 9.14e-04 | 6 | 158 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.11e-03 | 26 | 158 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.24e-03 | 27 | 158 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | sphingosine N-acyltransferase activity | 1.27e-03 | 7 | 158 | 2 | GO:0050291 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.53e-03 | 29 | 158 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | signal recognition particle binding | 1.69e-03 | 8 | 158 | 2 | GO:0005047 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 1.86e-03 | 31 | 158 | 3 | GO:0080025 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 3.73e-06 | 5 | 150 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | autophagy of mitochondrion | 2.01e-05 | 114 | 150 | 7 | GO:0000422 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 2.06e-05 | 8 | 150 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | mitochondrion organization | ATG9B HRK SLC25A4 SLC25A5 SLC25A6 NIPSNAP2 TWNK STOX1 TOMM70 ATAD3C PKD1 TIMM29 CERS1 WIPI2 PINK1 | 2.67e-05 | 589 | 150 | 15 | GO:0007005 |
| GeneOntologyBiologicalProcess | cellular catabolic process | HEXB CYP1A1 ENPP7 ATG9B CYP2D7 CYP2D6 SLC25A4 SLC25A5 TICAM1 NIPSNAP2 BCKDHA CPT1B ITGB4 CYP2W1 PHKG2 GCAT HOGA1 UCHL1 CERS1 HSD17B4 WIPI2 PINK1 HDC | 3.73e-05 | 1253 | 150 | 23 | GO:0044248 |
| GeneOntologyBiologicalProcess | catechol-containing compound biosynthetic process | 5.54e-05 | 29 | 150 | 4 | GO:0009713 | |
| GeneOntologyBiologicalProcess | catecholamine biosynthetic process | 5.54e-05 | 29 | 150 | 4 | GO:0042423 | |
| GeneOntologyBiologicalProcess | ADP transport | 7.90e-05 | 12 | 150 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | ammonium ion metabolic process | 8.25e-05 | 32 | 150 | 4 | GO:0097164 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 1.06e-04 | 148 | 150 | 7 | GO:0009308 | |
| GeneOntologyBiologicalProcess | serotonin biosynthetic process from tryptophan | 1.57e-04 | 3 | 150 | 2 | GO:0006587 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1.61e-04 | 15 | 150 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | regulation of mitophagy | 1.64e-04 | 38 | 150 | 4 | GO:1901524 | |
| GeneOntologyBiologicalProcess | ceramide metabolic process | 1.78e-04 | 113 | 150 | 6 | GO:0006672 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrion organization | 1.86e-04 | 162 | 150 | 7 | GO:0010821 | |
| GeneOntologyBiologicalProcess | ceramide biosynthetic process | 1.92e-04 | 73 | 150 | 5 | GO:0046513 | |
| GeneOntologyBiologicalProcess | positive regulation of mitophagy | 1.97e-04 | 16 | 150 | 3 | GO:1901526 | |
| GeneOntologyBiologicalProcess | mitophagy | 2.18e-04 | 75 | 150 | 5 | GO:0000423 | |
| GeneOntologyBiologicalProcess | TORC2 signaling | 2.38e-04 | 17 | 150 | 3 | GO:0038203 | |
| GeneOntologyBiologicalProcess | regulation of autophagy of mitochondrion | 3.18e-04 | 45 | 150 | 4 | GO:1903146 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy of mitochondrion | 3.35e-04 | 19 | 150 | 3 | GO:1903599 | |
| GeneOntologyBiologicalProcess | aromatic amino acid metabolic process | 3.46e-04 | 46 | 150 | 4 | GO:0009072 | |
| GeneOntologyBiologicalProcess | biogenic amine biosynthetic process | 3.76e-04 | 47 | 150 | 4 | GO:0042401 | |
| GeneOntologyBiologicalProcess | mitochondrial membrane organization | 3.96e-04 | 131 | 150 | 6 | GO:0007006 | |
| GeneOntologyBiologicalProcess | amine biosynthetic process | 4.08e-04 | 48 | 150 | 4 | GO:0009309 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 4.23e-04 | 307 | 150 | 9 | GO:0018105 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.43e-05 | 19 | 114 | 4 | M47760 | |
| Pathway | REACTOME_XENOBIOTICS | 4.50e-05 | 25 | 114 | 4 | MM14846 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 5.93e-05 | 10 | 114 | 3 | M47694 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 8.24e-05 | 29 | 114 | 4 | M12524 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.07e-04 | 12 | 114 | 3 | M27728 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | HEXB CERS2 CYP1A1 ENPP7 CYP2D7 CYP2D6 ACSF2 CPT1B FDXR HELZ2 ALB DEGS2 CERS1 HSD17B4 PLEKHA8 | 1.38e-04 | 620 | 114 | 15 | MM15193 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.39e-04 | 13 | 114 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.39e-04 | 13 | 114 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.39e-04 | 13 | 114 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.76e-04 | 14 | 114 | 3 | M47692 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.91e-04 | 66 | 114 | 5 | MM14839 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.06e-04 | 105 | 114 | 6 | MM14842 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 2.18e-04 | 15 | 114 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.67e-04 | 16 | 114 | 3 | M47695 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.85e-04 | 18 | 114 | 3 | M47659 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.85e-04 | 18 | 114 | 3 | MM14843 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 3.85e-04 | 18 | 114 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 4.54e-04 | 19 | 114 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 5.31e-04 | 20 | 114 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 6.16e-04 | 21 | 114 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.09e-04 | 22 | 114 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.09e-04 | 22 | 114 | 3 | M47675 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 7.09e-04 | 22 | 114 | 3 | MM15614 | |
| Pathway | REACTOME_XENOBIOTICS | 8.11e-04 | 23 | 114 | 3 | M5372 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 8.11e-04 | 23 | 114 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.11e-04 | 23 | 114 | 3 | M47676 | |
| Pathway | REACTOME_SPHINGOLIPID_METABOLISM | 8.90e-04 | 92 | 114 | 5 | MM15086 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 1.04e-03 | 25 | 114 | 3 | MM15931 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 1.17e-03 | 26 | 114 | 3 | M39784 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 1.17e-03 | 26 | 114 | 3 | MM15892 | |
| Pathway | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | 1.31e-03 | 27 | 114 | 3 | MM14646 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 1.31e-03 | 27 | 114 | 3 | M39863 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.31e-03 | 59 | 114 | 4 | M27218 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048 | 1.33e-03 | 7 | 114 | 2 | M47707 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.54e-03 | 104 | 114 | 5 | M738 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 9.56e-08 | 3 | 160 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 9.56e-08 | 3 | 160 | 3 | 2829183 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | DMGDH CYP1A1 RSAD1 SLC25A4 SLC25A5 SLC25A6 TRMT1 NIPSNAP2 TWNK BCKDHA ACSF2 HPDL TOMM70 TRAP1 GCAT NT5DC2 HOGA1 FDXR TIMM29 PINK1 | 3.08e-07 | 1136 | 160 | 20 | 34800366 |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 33396658 | ||
| Pubmed | 1.89e-06 | 6 | 160 | 3 | 10620603 | ||
| Pubmed | Polymorphism of metabolic genes and susceptibility to occupational chronic manganism. | 1.89e-06 | 6 | 160 | 3 | 12171760 | |
| Pubmed | MAPKAP1 CDC42BPG SLC25A4 NOL6 RHBDD2 LAMB3 TOMM70 FREM2 ARAP3 AP5B1 ARMC5 TIMM29 HSD17B4 PLXNB1 | 2.08e-06 | 650 | 160 | 14 | 38777146 | |
| Pubmed | 2.26e-06 | 82 | 160 | 6 | 20833797 | ||
| Pubmed | 3.30e-06 | 7 | 160 | 3 | 21370995 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 RHBDF2 HECTD4 TRMT1 LAMB3 TWNK ITGA3 EDC4 ADGRA2 ITGB4 RYR1 ARAP3 IL17RE PKD1 HELZ2 SMURF2 WNK2 TJP3 | 3.71e-06 | 1105 | 160 | 18 | 35748872 |
| Pubmed | Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. | 4.27e-06 | 24 | 160 | 4 | 24725412 | |
| Pubmed | 5.26e-06 | 8 | 160 | 3 | 27641616 | ||
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 5.26e-06 | 8 | 160 | 3 | 23529140 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 6.74e-06 | 212 | 160 | 8 | 33853758 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | DMGDH RSAD1 SLC25A4 SLC25A5 NIPSNAP2 TWNK BCKDHA ACSF2 CPT1B TOMM70 TRAP1 ATAD3C GCAT HOGA1 FDXR HSD17B4 PINK1 | 7.33e-06 | 1047 | 160 | 17 | 18614015 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CDC42BPG SLC25A5 LAMB3 MAGEE2 STOX1 CPT1B TEKT5 RYR1 CHRNB4 FREM2 HECW2 ALDH16A1 PKD1 ALB | 8.58e-06 | 736 | 160 | 14 | 29676528 |
| Pubmed | DMGDH SLC25A5 NIPSNAP2 BCKDHA CPT1B YWHAE TOMM70 TRAP1 ATAD3C GCAT HOGA1 FDXR | 8.69e-06 | 542 | 160 | 12 | 14651853 | |
| Pubmed | EMC4 SLC25A4 SLC25A5 NIPSNAP2 BCKDHA ACSF2 YWHAE TOMM70 TRAP1 UCHL1 ALDH16A1 FDXR ALB HSD17B4 PINK1 | 1.12e-05 | 859 | 160 | 15 | 31536960 | |
| Pubmed | Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75. | 1.12e-05 | 10 | 160 | 3 | 30590033 | |
| Pubmed | SLC25A4 SLC25A5 NIPSNAP2 BCKDHA ACSF2 CPT1B TOMM70 TRAP1 ATAD3C HSD17B4 | 1.20e-05 | 382 | 160 | 10 | 29222160 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HEXB CERS2 USP34 EMC4 SLC25A4 SLC25A5 CD109 RHBDD2 BCKDHA ACSF2 HPDL YWHAE LCMT2 TRAP1 ANGPTL2 ATAD3C GCAT NT5DC2 FDXR HSD17B4 | 1.24e-05 | 1451 | 160 | 20 | 30550785 |
| Pubmed | 1.47e-05 | 236 | 160 | 8 | 36339263 | ||
| Pubmed | 1.53e-05 | 11 | 160 | 3 | 10811835 | ||
| Pubmed | 2.04e-05 | 12 | 160 | 3 | 16120388 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 22281432 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 18224668 | ||
| Pubmed | Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients. | 2.10e-05 | 2 | 160 | 2 | 24449363 | |
| Pubmed | CYP1A1 and CYP2D6 Polymorphisms and Susceptibility to Chronic Myelocytic Leukaemia. | 2.10e-05 | 2 | 160 | 2 | 32418524 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26398595 | ||
| Pubmed | CYP1A1 and CYP2D6 gene polymorphisms in Israeli Jewish women with cervical cancer. | 2.10e-05 | 2 | 160 | 2 | 20009880 | |
| Pubmed | CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population. | 2.10e-05 | 2 | 160 | 2 | 14602525 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25808902 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11207030 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15648054 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23472196 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 26842067 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 2.10e-05 | 2 | 160 | 2 | 14749836 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16888648 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 34115022 | ||
| Pubmed | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | 2.10e-05 | 2 | 160 | 2 | 3123997 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23891063 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 11784011 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27162368 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 12112115 | ||
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 2.10e-05 | 2 | 160 | 2 | 10926541 | |
| Pubmed | Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells. | 2.10e-05 | 2 | 160 | 2 | 11032406 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 29196503 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 24006899 | ||
| Pubmed | Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas. | 2.10e-05 | 2 | 160 | 2 | 9034327 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 25138301 | ||
| Pubmed | PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. | 2.10e-05 | 2 | 160 | 2 | 17579517 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 27048932 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 16556444 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 2823266 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 23525905 | ||
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 19594327 | ||
| Pubmed | Coding-noncoding gene expression in intrahepatic cholangiocarcinoma. | 2.10e-05 | 2 | 160 | 2 | 26297049 | |
| Pubmed | Lineage-specific expression of bestrophin-2 and bestrophin-4 in human intestinal epithelial cells. | 2.10e-05 | 2 | 160 | 2 | 24223998 | |
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 2.10e-05 | 2 | 160 | 2 | 10974536 | |
| Pubmed | 2.10e-05 | 2 | 160 | 2 | 15051713 | ||
| Pubmed | Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. | 2.10e-05 | 2 | 160 | 2 | 31990681 | |
| Pubmed | The role of the individual TOM subunits in the association of PINK1 with depolarized mitochondria. | 2.10e-05 | 2 | 160 | 2 | 35391620 | |
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 2.10e-05 | 2 | 160 | 2 | 11756613 | |
| Pubmed | Mitochondrial Protein Interaction Mapping Identifies Regulators of Respiratory Chain Function. | SLC25A4 SLC25A5 SLC25A6 TRMT1 NIPSNAP2 BCKDHA ACSF2 NT5DC2 HOGA1 TIMM29 | 2.34e-05 | 413 | 160 | 10 | 27499296 |
| Pubmed | 2.53e-05 | 37 | 160 | 4 | 19865483 | ||
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | DMGDH RSAD1 SLC25A4 NIPSNAP2 TWNK BCKDHA ACSF2 CPT1B TOMM70 TRAP1 GCAT HOGA1 FDXR HSD17B4 PINK1 | 2.67e-05 | 926 | 160 | 15 | 20877624 |
| Pubmed | 3.35e-05 | 14 | 160 | 3 | 12919677 | ||
| Pubmed | 4.17e-05 | 15 | 160 | 3 | 19725078 | ||
| Pubmed | SLC25A5 SLC25A6 MYH7B USP24 ACSF2 YWHAE TOMM70 TRAP1 ATAD3C UCHL1 ALDH16A1 FDXR HSD17B4 DYNC1I2 | 5.91e-05 | 878 | 160 | 14 | 37223481 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20302855 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 29040572 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 17420318 | ||
| Pubmed | CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China. | 6.29e-05 | 3 | 160 | 2 | 23471717 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 38375821 | ||
| Pubmed | Mechanism of human PINK1 activation at the TOM complex in a reconstituted system. | 6.29e-05 | 3 | 160 | 2 | 38848361 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 18400985 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 2574001 | ||
| Pubmed | Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). | 6.29e-05 | 3 | 160 | 2 | 12707443 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 20181062 | ||
| Pubmed | Albumin Overload and PINK1/Parkin Signaling-Related Mitophagy in Renal Tubular Epithelial Cells. | 6.29e-05 | 3 | 160 | 2 | 29494565 | |
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 11037802 | ||
| Pubmed | 6.29e-05 | 3 | 160 | 2 | 16831128 | ||
| Pubmed | Identification of the primary gene defect at the cytochrome P450 CYP2D locus. | 6.29e-05 | 3 | 160 | 2 | 1978251 | |
| Pubmed | ANT1, Twinkle, POLG, and TP: new genes open our eyes to ophthalmoplegia. | 6.29e-05 | 3 | 160 | 2 | 11756592 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 7.41e-05 | 18 | 160 | 3 | 12119179 | |
| Pubmed | 9.77e-05 | 99 | 160 | 5 | 29676259 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | MIIP EMC4 SLC25A5 MYO9A TRMT1 ACSF2 ITGB4 TRAP1 ALDH16A1 ARMC5 PKD1 HSD17B4 DYNC1I2 BRWD1 | 1.02e-04 | 925 | 160 | 14 | 28986522 |
| Pubmed | 1.20e-04 | 21 | 160 | 3 | 27856617 | ||
| Pubmed | SLC25A4 SLC25A5 SLC25A6 KDM5A MYH7B NOL6 NIPSNAP2 TWNK TRIM43 STOX1 SPTBN4 CCDC27 TRAP1 ATAD3C NRXN1 HSD17B4 SMURF2 DYNC1I2 | 1.22e-04 | 1442 | 160 | 18 | 35575683 | |
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 1.24e-04 | 238 | 160 | 7 | 35864588 | |
| Pubmed | Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? | 1.25e-04 | 4 | 160 | 2 | 12748560 | |
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 18414197 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 22423112 | ||
| Pubmed | 1.25e-04 | 4 | 160 | 2 | 15769360 | ||
| Pubmed | Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes. | 1.25e-04 | 4 | 160 | 2 | 16707493 | |
| Pubmed | Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. | 1.25e-04 | 4 | 160 | 2 | 31489369 | |
| Pubmed | Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. | 1.25e-04 | 4 | 160 | 2 | 16493615 | |
| Pubmed | Novel Twinkle (PEO1) gene mutations in mendelian progressive external ophthalmoplegia. | 1.25e-04 | 4 | 160 | 2 | 18575922 | |
| Pubmed | Three novel human VMD2-like genes are members of the evolutionary highly conserved RFP-TM family. | 1.25e-04 | 4 | 160 | 2 | 12032738 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | AMH CPAMD8 ADAT3 BEST2 TICAM1 AZU1 TRMT1 NIBAN3 TIMM29 CERS1 MAST3 TJP3 | 2.56e-05 | 797 | 160 | 12 | chr19p13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 1.70e-04 | 330 | 160 | 7 | chr22q13 | |
| Cytoband | 17q21.33 | 4.02e-04 | 41 | 160 | 3 | 17q21.33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 5.49e-04 | 189 | 160 | 5 | chr10q24 | |
| Cytoband | 1p34.1 | 1.06e-03 | 57 | 160 | 3 | 1p34.1 | |
| Cytoband | Yp11.3 | 1.40e-03 | 16 | 160 | 2 | Yp11.3 | |
| Cytoband | 19p13.3 | 1.51e-03 | 237 | 160 | 5 | 19p13.3 | |
| GeneFamily | Rhomboid family | 6.24e-05 | 14 | 103 | 3 | 926 | |
| GeneFamily | Bestrophins | 1.91e-04 | 4 | 103 | 2 | 866 | |
| GeneFamily | CERS class homeoboxes | 4.75e-04 | 6 | 103 | 2 | 530 | |
| GeneFamily | Cytochrome P450 family 2 | 1.03e-03 | 35 | 103 | 3 | 1001 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.13e-03 | 9 | 103 | 2 | 1234 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.15e-07 | 198 | 160 | 8 | 2e6630eab77b12a6059682ab5ba465f38e469102 | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.63e-07 | 200 | 160 | 8 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-06 | 164 | 160 | 7 | cf62d34ce9dd220fe61748466c84fd70d9ba697c | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-06 | 164 | 160 | 7 | e00549bc8b3a5566f39031f39d7e698b0b107a7f | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 2.29e-06 | 165 | 160 | 7 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 2.38e-06 | 166 | 160 | 7 | 20f248d95c86eb52a1efe9abe73123fbe4206caf | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Mast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.01e-06 | 172 | 160 | 7 | a7146c255031207e64682ef767884b11c96e0d59 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.13e-06 | 173 | 160 | 7 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.13e-06 | 173 | 160 | 7 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue | 3.25e-06 | 174 | 160 | 7 | 029394e107bf7ad58056d2216070aa2e964fff12 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.78e-06 | 178 | 160 | 7 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-06 | 178 | 160 | 7 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-06 | 178 | 160 | 7 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | normal-na-Lymphocytic_B-plasmablast-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.78e-06 | 178 | 160 | 7 | 40a280c1e35963dd45d1809a3e85b568344dd1f5 | |
| ToppCell | normal-na-Lymphocytic_B-plasmablast|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.78e-06 | 178 | 160 | 7 | 4fe87c713770173336177e3488f7b4a3be54f71b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.78e-06 | 178 | 160 | 7 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 181 | 160 | 7 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 181 | 160 | 7 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 181 | 160 | 7 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.37e-06 | 182 | 160 | 7 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 4.37e-06 | 182 | 160 | 7 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 4.37e-06 | 182 | 160 | 7 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.37e-06 | 182 | 160 | 7 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.37e-06 | 182 | 160 | 7 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.37e-06 | 182 | 160 | 7 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.37e-06 | 182 | 160 | 7 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.37e-06 | 182 | 160 | 7 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.87e-06 | 185 | 160 | 7 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | mild_COVID-19-Plasmablast|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.04e-06 | 186 | 160 | 7 | a639d2183b85b1be6e6da2b2e112aec5149d5bcd | |
| ToppCell | mild_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 5.41e-06 | 188 | 160 | 7 | 9a5ba6abdc307402301dae25db2a5f3e0d576417 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-06 | 189 | 160 | 7 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, Lineage and Cell Type | 5.60e-06 | 189 | 160 | 7 | 6339b6d1056e07cefb0e1b2a0e479913c5783c8a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 189 | 160 | 7 | 96566f84c796d5b2e31f64090555f2b258f0c9f2 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 189 | 160 | 7 | b59cc66f7bb9b72895b775fbcf1ec1dc08610969 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 189 | 160 | 7 | 1893765b1e3b306f1e133101c28403070a70c3c8 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-06 | 189 | 160 | 7 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-06 | 189 | 160 | 7 | 19b639bc6b35fe1d1079f60c8138aa946a95f3bf | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.80e-06 | 190 | 160 | 7 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.80e-06 | 190 | 160 | 7 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-06 | 193 | 160 | 7 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-06 | 194 | 160 | 7 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.65e-06 | 194 | 160 | 7 | fcbf9c4f3801ab1a34fcd62c752fabc97fc7bde1 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.87e-06 | 195 | 160 | 7 | fbedb9978ded857fd35c2a8664f7579f42edaa36 | |
| ToppCell | distal-Hematologic-Plasma-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.87e-06 | 195 | 160 | 7 | 4280a5bc5ed9bb12e278b182e0be6cb88fa83d83 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.87e-06 | 195 | 160 | 7 | 9c24ebce2e3e00b8b692c62a22a53b7d59f0eabb | |
| ToppCell | distal-Hematologic-Plasma-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.11e-06 | 196 | 160 | 7 | 8201aded3c7109fae5e6ca12bac2076acc7bf070 | |
| ToppCell | distal-1-Hematologic-Plasma|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.35e-06 | 197 | 160 | 7 | f5499bfa9dbc111f12563b7006bc45c2423ad0cd | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.35e-06 | 197 | 160 | 7 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-06 | 198 | 160 | 7 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, condition lineage and cell class | 7.59e-06 | 198 | 160 | 7 | c30b71b998acde080adb90a2016a165c5ed17a81 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, condition lineage and cell class | 7.59e-06 | 198 | 160 | 7 | 614055c11d1dd2f3f2b8783ec35a8f4570cad161 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.59e-06 | 198 | 160 | 7 | a1247a5efd92f95c6227c0e71dc8a0427eb54b7f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.11e-06 | 200 | 160 | 7 | 73bfdf068a8ecbefc1e6afe9686df73658ee042f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Papillary_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.70e-06 | 133 | 160 | 6 | b6d0fe227faec9c119498b5b9cec2a755ec29c00 | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.66e-05 | 149 | 160 | 6 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-stem_cells_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.86e-05 | 152 | 160 | 6 | 375c9ef88c7703a002e868645a722c35e046ef1e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.86e-05 | 152 | 160 | 6 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.86e-05 | 152 | 160 | 6 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 155 | 160 | 6 | 29c4e9947bb4f7e257ed5c3bcf21bd67f88d473f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Papillary_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.08e-05 | 155 | 160 | 6 | 57259549d7ad97d9f628b821417be5ddac7dbff7 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Testicular_Germ_Cell_Tumor|TCGA-Testes / Sample_Type by Project: Shred V9 | 2.15e-05 | 156 | 160 | 6 | f9eb18a0f00de211fab36d7d88fcf08276d53dcc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 162 | 160 | 6 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 162 | 160 | 6 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 162 | 160 | 6 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 162 | 160 | 6 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.76e-05 | 163 | 160 | 6 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.76e-05 | 163 | 160 | 6 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 2.85e-05 | 164 | 160 | 6 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 2.95e-05 | 165 | 160 | 6 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 2.95e-05 | 165 | 160 | 6 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-05 | 165 | 160 | 6 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 165 | 160 | 6 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.06e-05 | 166 | 160 | 6 | 0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1 | |
| ToppCell | ICU-SEP-Lymphocyte-B-Plasmablast|ICU-SEP / Disease, Lineage and Cell Type | 3.06e-05 | 166 | 160 | 6 | 98ce43e14133418f676f1c88c001add9e28259a7 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.38e-05 | 169 | 160 | 6 | 9ab34f602d46ce87283d243b81621e8806504f43 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.38e-05 | 169 | 160 | 6 | 89fbafdb4628ce7a90c50398870e0f8ee90cfd91 | |
| ToppCell | BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.38e-05 | 169 | 160 | 6 | 75d367eb35768d3063096e8866cea649dac3b1bd | |
| ToppCell | 3'_v3-blood-Hematopoietic_progenitors-HSC-MPP|blood / Manually curated celltypes from each tissue | 3.49e-05 | 170 | 160 | 6 | 1443d7fccc81088dd42dcbb9361e269872542274 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.49e-05 | 170 | 160 | 6 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | Ionocyte|World / Class top | 3.49e-05 | 170 | 160 | 6 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 3.49e-05 | 170 | 160 | 6 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.61e-05 | 171 | 160 | 6 | 0f8d038858a4618b4348becc26a618d43b10d9d6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.61e-05 | 171 | 160 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.61e-05 | 171 | 160 | 6 | 791d37fe94ff2820fb409bbd38b31799df700ba1 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.61e-05 | 171 | 160 | 6 | 0bf36930bd7fc63691f48a15db93deb1dd937c10 | |
| ToppCell | Control-B_cell-Plasmablast|Control / Disease group,lineage and cell class (2021.01.30) | 3.61e-05 | 171 | 160 | 6 | c09afc4b111b2b5acca75177554f6364ee02d37c | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-05 | 172 | 160 | 6 | d40a8bd61114b49a5837c836136a13c37c8f7de0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-05 | 172 | 160 | 6 | 2ab720a4c96073339a1f8b95ec7699682df98acf | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 3.85e-05 | 173 | 160 | 6 | 5645a3b1e805c71d5d65fc8e4edc4e13208063fc | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue | 3.98e-05 | 174 | 160 | 6 | 6d9bdf4d28ff8ebb66ffd1ccdd6a4fe9440a83f3 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.98e-05 | 174 | 160 | 6 | e8d2aa9505817aac3fe068080774d19458f07b01 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.98e-05 | 174 | 160 | 6 | 36080fa12497faa752ff07ae52cd3864053eafef | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.98e-05 | 174 | 160 | 6 | bdbaf805a94b2f5a0065933dab6bf84e3cabd525 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.24e-05 | 176 | 160 | 6 | dc4e939a07bad21ab36181f9588df3fa662f9a92 | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 4.24e-05 | 176 | 160 | 6 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP|lymph-node_spleen / Manually curated celltypes from each tissue | 4.24e-05 | 176 | 160 | 6 | de67ed15a50d2515ba6d152c1011a3367f77aedd | |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | 4.37e-05 | 177 | 160 | 6 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-05 | 177 | 160 | 6 | ecd26d086c1aff3be442fcb055611a563ca034ef | |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | 4.37e-05 | 177 | 160 | 6 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d | |
| Drug | Clodronate | 3.34e-07 | 3 | 159 | 3 | DB00720 | |
| Drug | AC1L4X2K | 4.65e-07 | 10 | 159 | 4 | CID000193824 | |
| Drug | 16 alpha-hydroxytestosterone | 1.09e-06 | 12 | 159 | 4 | CID000065545 | |
| Drug | dehydroabietylamine | 1.33e-06 | 4 | 159 | 3 | ctd:C000600819 | |
| Drug | oxosparteine | 3.31e-06 | 5 | 159 | 3 | CID000097492 | |
| Drug | mono-(2-ethylhexyl)phthalate | B3GALT2 CYP1A1 AMH RHOD CD109 ITGA3 ITGB4 RYR1 SPTBN4 CCDC27 HECW2 DERL3 FDXR BRSK1 HSD17B4 LY75 WNK2 | 3.79e-06 | 658 | 159 | 17 | ctd:C016599 |
| Drug | oleoylcarnitine | 3.90e-06 | 16 | 159 | 4 | CID006441392 | |
| Drug | beta-hydroxypalmitoyl-CoA | 5.08e-06 | 17 | 159 | 4 | CID000440600 | |
| Drug | chlorpheniramine | 5.67e-06 | 37 | 159 | 5 | CID000002725 | |
| Drug | closantel | 1.15e-05 | 7 | 159 | 3 | ctd:C023342 | |
| Drug | diclofenac | CYP1A1 CYP2D7 CYP2D6 SLC25A4 SLC25A5 SLC25A6 USP24 CYP2W1 ALB | 1.69e-05 | 209 | 159 | 9 | CID000003032 |
| Drug | Z H-H | 1.82e-05 | 8 | 159 | 3 | CID000004657 | |
| Drug | AC1L1AH5 | 2.11e-05 | 215 | 159 | 9 | CID000000986 | |
| Drug | tyramine | 3.65e-05 | 130 | 159 | 7 | CID000005610 | |
| Drug | benzaldehyde oxime | 3.87e-05 | 10 | 159 | 3 | CID000012143 | |
| Drug | cupreidine | 4.85e-05 | 2 | 159 | 2 | CID000051196 | |
| Drug | MK785 | 4.85e-05 | 2 | 159 | 2 | CID000192909 | |
| Drug | 3-methoxyphenethylamine | 4.85e-05 | 2 | 159 | 2 | CID000074866 | |
| Drug | 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole | 4.85e-05 | 2 | 159 | 2 | ctd:C507816 | |
| Drug | 8-hydroxycarteolol | 5.29e-05 | 11 | 159 | 3 | CID000124688 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 3.65e-07 | 29 | 152 | 5 | DOID:11984 (implicated_via_orthology) | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 5.34e-07 | 4 | 152 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 2.65e-06 | 6 | 152 | 3 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 4.62e-06 | 7 | 152 | 3 | DOID:3209 (is_implicated_in) | |
| Disease | Occupational Diseases | 2.15e-05 | 11 | 152 | 3 | C0028797 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 3.13e-05 | 35 | 152 | 4 | DOID:700 (implicated_via_orthology) | |
| Disease | chronic progressive external ophthalmoplegia (is_implicated_in) | 7.88e-05 | 3 | 152 | 2 | DOID:12558 (is_implicated_in) | |
| Disease | fibulin-1 measurement | 7.88e-05 | 3 | 152 | 2 | EFO_0802550 | |
| Disease | Herlitz Disease | 1.57e-04 | 4 | 152 | 2 | C0079683 | |
| Disease | solanidine measurement | 1.57e-04 | 4 | 152 | 2 | EFO_0800966 | |
| Disease | Epidermolysis Bullosa Progressiva | 1.57e-04 | 4 | 152 | 2 | C0079297 | |
| Disease | Hepatomegaly | 1.75e-04 | 54 | 152 | 4 | C0019209 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 2.61e-04 | 5 | 152 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 2.61e-04 | 5 | 152 | 2 | C2608084 | |
| Disease | Perrault syndrome (is_implicated_in) | 2.61e-04 | 5 | 152 | 2 | DOID:0050857 (is_implicated_in) | |
| Disease | Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1 | 2.61e-04 | 5 | 152 | 2 | C1834846 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 2.61e-04 | 5 | 152 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Perrault syndrome | 3.90e-04 | 6 | 152 | 2 | cv:C0685838 | |
| Disease | oral cavity cancer (is_implicated_in) | 3.90e-04 | 6 | 152 | 2 | DOID:8618 (is_implicated_in) | |
| Disease | Gonadal dysgenesis XX type deafness | 5.44e-04 | 7 | 152 | 2 | C0685838 | |
| Disease | plasma betaine measurement | 7.13e-04 | 34 | 152 | 3 | EFO_0007787 | |
| Disease | neuroimaging measurement, brain volume measurement | 7.31e-04 | 286 | 152 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | HOYERAAL-HREIDARSSON SYNDROME | 1.15e-03 | 10 | 152 | 2 | C1846142 | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.15e-03 | 10 | 152 | 2 | EFO_0008200 | |
| Disease | Malignant neoplasm of breast | CYP1A1 ADAT3 CYP2D6 RIBC2 TICAM1 CD109 TECTA PKDREJ MAMDC4 ARAP3 ROBO1 PLEKHA8 PLXNB1 NLRP8 | 1.36e-03 | 1074 | 152 | 14 | C0006142 |
| Disease | urate measurement | CERS2 CYP1A1 USP34 CDC42BPG MYO9A HECTD4 TRAP1 NRXN1 AP5B1 ALDH16A1 CCDC17 MAST3 | 2.38e-03 | 895 | 152 | 12 | EFO_0004531 |
| Disease | eosinophil measurement | 2.40e-03 | 108 | 152 | 4 | EFO_0803540 | |
| Disease | ankylosing spondylitis (is_implicated_in) | 4.26e-03 | 19 | 152 | 2 | DOID:7147 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 4.26e-03 | 19 | 152 | 2 | OBA_2045199 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFWLRSSGRFRQDVQ | 411 | P30926 | |
| VWFTNLAAQARRDGR | 186 | Q8NFU0 | |
| NVIGARRASWRIISS | 51 | P62258 | |
| ASVGRLQWRRVSAQE | 506 | Q6UXC1 | |
| VWAARRAAARGLRAV | 181 | Q96EY9 | |
| VWFSNLAAQARREGR | 186 | Q8NFU1 | |
| GVLSFWRGNLANVIR | 66 | P12236 | |
| LGLFDQDQRVLSGRW | 496 | Q96LX7 | |
| GLRRRALGAVFATWR | 1051 | Q5SNV9 | |
| GERAFKAWAVARLSQ | 231 | P02768 | |
| VLGNDRANRFWAGTL | 561 | Q8WWN8 | |
| RQWQLFGTQASRAVR | 96 | Q15834 | |
| LSARRLRAWGARVQA | 626 | Q8IZ83 | |
| ERVANNRGDFRWPRT | 356 | Q96PE1 | |
| RAWGLRFFRSPQQVL | 301 | P22570 | |
| EAAQVAFQRGSPWRR | 76 | P47895 | |
| AFQRGSPWRRLDALS | 81 | P47895 | |
| GVLSFWRGNLANVIR | 66 | P05141 | |
| FSSGARWRAARQFTV | 116 | Q8TAV3 | |
| ERAQGGSFRSLRSWL | 446 | Q96C12 | |
| RSLLQRWGASFRRGA | 6 | Q96BJ3 | |
| ALGAWRGRERAQAAT | 16 | A8MUL3 | |
| LGARAALSRSWQEAR | 21 | Q96CM8 | |
| WQEARLQGVRFLSSR | 31 | Q96CM8 | |
| RRLDGSVNFFRNWET | 321 | Q9UKU9 | |
| GVASGQRRSWLIIQR | 191 | P19801 | |
| VWSRRSPRVRVNFFG | 131 | Q96Q80 | |
| RLSNQAFVFRGGRWT | 126 | A6NI87 | |
| IAVDFWSLRRAGTAR | 11 | Q9H816 | |
| QSGLSGRQVERWFRR | 106 | Q96G23 | |
| WRGTQDLFLARRGSD | 166 | Q2M243 | |
| WARAIRFRQDGNEAV | 206 | O75323 | |
| GRLDAARGRVSWQVE | 321 | Q7Z6P3 | |
| DSGPVWAARRRLAQN | 126 | P04798 | |
| FWRFLITGADQNREL | 366 | Q6P2E9 | |
| GVRRGWQRVFAALSD | 961 | Q6DT37 | |
| KSDSGLAQRRFIRGW | 516 | Q86XR2 | |
| VRGRVQSFWGSEAAL | 166 | Q5SQ64 | |
| RGRRSFIFKGEDNWA | 171 | Q8IZ07 | |
| VWQRRGSLEGAAAAA | 736 | Q9P2P5 | |
| RVGNLISQIRGARAW | 486 | P19113 | |
| RAAAAQSRWGRASRA | 6 | Q7RTS5 | |
| RQGLSRSLSRNVGVW | 11 | Q86XE5 | |
| ANVWNLLRRFSVDVG | 421 | Q8TD90 | |
| AYQVLSGGWRNRRVA | 211 | Q9NS87 | |
| RFPGRRAWDVTSNIF | 91 | Q86W28 | |
| GQTRATWRVRILSDG | 1831 | Q5SZK8 | |
| LWAARTRVAREQGTV | 541 | Q8NFR9 | |
| FAEATSWGRLGARQR | 631 | Q8NFR9 | |
| WARFGRTLAEINANR | 611 | Q13409 | |
| QRLLGGRDALFTIQW | 851 | A7E2Y1 | |
| GRDALFTIQWNIRAF | 856 | A7E2Y1 | |
| AVWFGATERRLQRGQ | 1231 | O43157 | |
| GLAARLQRQFVVRAW | 76 | Q9BXM7 | |
| DRVRVNGWATLFLRT | 946 | P26006 | |
| AEARARWGATLRNFS | 66 | Q9HB15 | |
| VQGALWQIFLGRRSL | 306 | P47893 | |
| IGRFWATVAREGNSA | 146 | Q8TDF6 | |
| QFWGSRSELRRFQDG | 581 | Q9H6R4 | |
| FSGVARLAKRWVRAQ | 851 | Q9H6R4 | |
| LFVRRNQGAEQWRSA | 211 | P55160 | |
| LRVAVRGAFVSLWFA | 86 | Q96EZ4 | |
| WATVGGRRRAVTFSN | 571 | O60449 | |
| GRRRAVTFSNWNFLE | 576 | O60449 | |
| NARRFSAGQWEARRG | 436 | Q9Y4W2 | |
| AVQRARWGPRDLATF | 86 | P03971 | |
| QLDERGRQRGDFSLW | 121 | P18627 | |
| RDAWAQRLGAFRASP | 6 | Q2VPB7 | |
| LFWVPRGRRAQSALA | 11 | O75600 | |
| LSNVEQAAGLRWSRF | 381 | Q96RR1 | |
| QAAGLRWSRFPDLNR | 386 | Q96RR1 | |
| GWVVRGVFALALRAA | 446 | Q96JA3 | |
| DGAWHSVRIRRQFRN | 111 | Q9ULB1 | |
| RDAFTLQVWLRAEGG | 116 | Q13219 | |
| FLLAAQTRWRRGNTR | 1181 | Q9Y4D8 | |
| GARATLLFERQQWRR | 321 | Q9H4K1 | |
| YVFRVRAQSQEGWGR | 1596 | P16144 | |
| QRFRVAVWTVLAAGR | 306 | P15735 | |
| QVAAARAWRERTGRT | 1046 | P29375 | |
| VLSRWRVFAGAVAQA | 211 | P05981 | |
| SARLRAFGWQAAARL | 171 | Q8N4S7 | |
| SREVDGWRQLALRSG | 36 | Q96IR7 | |
| GWRQLALRSGDAVFL | 41 | Q96IR7 | |
| AAEVALSSRGRNFWR | 186 | O00212 | |
| LSSRGRNFWRRITQG | 191 | O00212 | |
| AELVRAARSWARVGA | 191 | C9JJ37 | |
| AARSWARVGAAVLER | 196 | C9JJ37 | |
| ARRAIRQTWGNESLA | 166 | O43825 | |
| RWLSRQRNSLGGFAS | 1166 | Q6YHK3 | |
| DWGATNARVGSLRRV | 156 | P07320 | |
| SSLRSRWGRFLLQRG | 61 | P15814 | |
| LRRRFGDVFSLQLAW | 61 | P10635 | |
| LLELGRRAWRFGVAA | 151 | Q8NHY3 | |
| RRAWRFGVAAPTLVQ | 156 | Q8NHY3 | |
| RFLNGQVVFEAWGRL | 66 | Q8NDZ4 | |
| RVHLRGSFQVTRAAW | 121 | P51659 | |
| RESRLFGAVVRWAEA | 236 | Q9H0C5 | |
| WAGLTAQRRRRSSVF | 661 | Q8IZJ3 | |
| ALLRSNIRRGAQDWA | 46 | Q5T5S1 | |
| AFGTGRAARNRWLAV | 96 | Q6QHC5 | |
| RAARNRWLAVFANLP | 101 | Q6QHC5 | |
| FDWANTSRRGLLLFV | 221 | Q5T2N8 | |
| QLVQRGWGSALAAAR | 21 | P27544 | |
| DQRGALAARWGRTVL | 426 | Q674R7 | |
| GAAWRSRLNSIRNSF | 546 | Q8TDC3 | |
| GSRDGTARIWRFEQL | 386 | Q9NSI6 | |
| LLWRRIARASLNSGF | 66 | P57775 | |
| ANRIVNAAGFWAREV | 241 | Q9UI17 | |
| QGFRFLRRRWGLSSL | 346 | Q9H992 | |
| LNFPFARRADGRRWS | 71 | O60307 | |
| GWLRGAAASRRLQQR | 171 | Q92837 | |
| FRRRGVDVSQVAWQS | 76 | P50053 | |
| ALRFGRLRNATASLW | 596 | Q13751 | |
| GLVANRGRRFKWAIE | 6 | Q5J8M3 | |
| IWITAQRQGLRAGSF | 126 | Q6UWV6 | |
| VRRTQAVELRGQAAW | 116 | Q9BYK8 | |
| QLQAAGRVRWARALY | 266 | O75791 | |
| KANRVWGALRGLETF | 161 | P07686 | |
| RVALFRDWIDGVLNN | 231 | P20160 | |
| AGRAAGAQRWRSENF | 41 | O75056 | |
| RTRVTWRNGLILGFS | 331 | A6NKX4 | |
| FLQVETRRAGERLGW | 1611 | P21817 | |
| AGGRVEWAQARQAFF | 386 | Q92523 | |
| TGFRAWNVQSRGRIF | 291 | O15259 | |
| VRLAQLGAADRQWTR | 3951 | P98161 | |
| LGAADRQWTRFVRGR | 3956 | P98161 | |
| AAARVWRLNRGLSQA | 6 | P12694 | |
| GLRRQRNYAGRWDVL | 466 | Q9BUJ2 | |
| AQVAALAAWLLGRRN | 76 | O00198 | |
| LGGNALDRVARAWFA | 261 | Q9GZU5 | |
| RGRWAQVFALLAQET | 141 | Q6P0A1 | |
| ARARGWAAAARAAQR | 6 | Q9HA92 | |
| RVLSRARFFEWQSPG | 16 | Q9NXH9 | |
| EGRTAFLWRGNVVLR | 161 | Q96BQ3 | |
| AQRLRQATTRAVEGW | 106 | Q2YD98 | |
| NFQASVGWLNRFRDR | 116 | Q17RP2 | |
| SEAFVQRLLWLRGRG | 106 | Q9BSF4 | |
| RRAFALLGWTGSRQF | 441 | P04053 | |
| LLGWTGSRQFERDLR | 446 | P04053 | |
| RWGSGTRANVFVQLR | 1241 | Q9NTG1 | |
| LWVGQDAVRRSVARA | 21 | Q5JXC2 | |
| WAGALAQERRFQLEG | 21 | O43699 | |
| WDFGIRRRSNTAQRL | 76 | Q9BPZ7 | |
| SQRLGLSEARVQVWF | 151 | O15266 | |
| QVRGAEASRLWASRL | 101 | Q96M29 | |
| SRAAGLGRRAVVWSL | 31 | Q9Y4P8 | |
| GELSQFNIWDRVLRA | 371 | P47972 | |
| LRAQWGIGDSIRASQ | 296 | Q86VW0 | |
| GFLSFWRGNLANVIR | 66 | P12235 | |
| LRRRFGDVFSLQLAW | 61 | A0A087X1C5 | |
| VNWRFLRGIEAQFLA | 586 | Q9HAU4 | |
| TSRGQFLRRGEVFWD | 261 | O75443 | |
| WSQRGSQIAFRLQVR | 41 | Q6UVY6 | |
| RLDGSDNRNDFWRLV | 96 | Q9UQR0 | |
| IIIWRFAGNFERTVG | 81 | Q6NTF9 | |
| ARLARAASRLAFQGW | 51 | Q6ZVD7 | |
| AASRLAFQGWLRRGV | 56 | Q6ZVD7 | |
| AFQGWLRRGVLLVRA | 61 | Q6ZVD7 | |
| ADAVARLVARQWAGV | 66 | Q8IUC6 | |
| ALRFAAAASWQVVRG | 11 | Q9BSI4 | |
| SAWAGLREAAERRQQ | 1601 | Q9H254 | |
| LGAGAIYLWSRQQRR | 51 | O94826 | |
| AIFWRREGSQNLLFS | 381 | Q9Y6N7 | |
| QGNLFDFLRLTEWRG | 336 | Q9H857 | |
| AGSNARAEFWRLRGL | 566 | O95049 | |
| RRNPAWSLQAGRLFS | 46 | Q12931 | |
| IRRWSSAQAREFGNL | 2326 | Q9UPU5 | |
| FWGIALRAQSGDVSR | 1101 | Q70CQ2 | |
| GTARRNQVWFGLRVP | 2251 | Q9Y3S1 | |
| VEAQRRRFLQAGWTA | 251 | O60294 | |
| LGVVGNWLNRSYRRS | 371 | Q6PJF5 | |
| LEAFGRLWQVQSRLG | 16 | Q8TAS1 | |
| IFNRVFNRLLWSRGQ | 766 | Q6ZT98 | |
| VLSRLGVAGQWRFVD | 16 | P09936 | |
| FSWFNVAEGRTRGRA | 271 | Q9H6D3 | |
| FDIAWNGRTGIRQSR | 796 | B2RTY4 |